prostate adenocarcinoma
Showing 26 - 50 of 187
Prostate Adenocarcinoma Trial in Rochester (Ulrasound Vibroelastography (UVE))
Suspended
- Prostate Adenocarcinoma
- Ulrasound Vibroelastography (UVE)
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 12, 2023
Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide
Not yet recruiting
- Prostate Adenocarcinoma
- +2 more
- Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
- Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 4, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial in Charlotte (ADT+Docetaxel+Enzalutamide)
Active, not recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
-
Charlotte, North CarolinaLevine Cancer Institute
Jan 12, 2023
Prostate Cancer, Prostate Cancer Metastatic, Prostate Adenocarcinoma Trial (Relugolix Pill, Ritonavir, Itraconazole)
Not yet recruiting
- Prostate Cancer
- +2 more
- Relugolix Pill
- +2 more
- (no location specified)
Dec 23, 2022
Localized Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Best Practice, Dietary Intervention, Exercise
Recruiting
- Localized Prostate Carcinoma
- Prostate Adenocarcinoma
- Best Practice
- +4 more
-
Seattle, Washington
- +1 more
Jan 9, 2023
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial in Philadelphia
Recruiting
- Prostate Adenocarcinoma
- +2 more
- MRI-guided Intensity-Modulated Radiation Therapy
- +7 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 4, 2023
Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Scottsdale, Rochester
Active, not recruiting
- Prostate Adenocarcinoma
- +5 more
- Androgen Suppression
- +3 more
-
Scottsdale, Arizona
- +1 more
Jan 5, 2023
Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester
Active, not recruiting
- Metastatic Prostate Adenocarcinoma
- +6 more
- Intensity-Modulated Radiation Therapy
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Prostate Adenocarcinoma Trial in Kansas City (Osanetant)
Recruiting
- Prostate Adenocarcinoma
-
Kansas City, KansasThe University of Kansas Cancer Center, Westwood Campus
Jan 3, 2023
Prostate Adenocarcinoma Trial in Kansas City (Osanetant)
Recruiting
- Prostate Adenocarcinoma
-
Kansas City, KansasThe University of Kansas Cancer Center, Westwood Campus
Jan 3, 2023
Prostate Adenocarcinoma, Localized Prostate Carcinoma Trial in San Francisco (High Dose Rate Monotherapy)
Not yet recruiting
- Prostate Adenocarcinoma
- Localized Prostate Carcinoma
- High Dose Rate Monotherapy
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 27, 2022
Work Experience in Patients With Stage I-III Prostate Cancer
Recruiting
- Prostate Adenocarcinoma
- +3 more
- Interview
- Questionnaire Administration
-
Phoenix, Arizona
- +324 more
Dec 21, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial in Tampa (Sunphenon, Placebo)
Recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Sunphenon
- Placebo
-
Tampa, Florida
- +1 more
Dec 19, 2022
Prostate Adenocarcinoma Trial in Columbus (Dietary Intervention, Questionnaire Administration)
Active, not recruiting
- Prostate Adenocarcinoma
- Dietary Intervention
- Questionnaire Administration
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 9, 2022
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)
Active, not recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Abiraterone Acetate
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8
Recruiting
- Prostate Adenocarcinoma
- +5 more
- Discussion
- +5 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Dec 1, 2022
Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial
Active, not recruiting
- Hormone-Resistant Prostate Cancer
- +6 more
- Pembrolizumab
- pTVG-HP Plasmid DNA Vaccine
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Nov 8, 2022
Male Erectile Disorder, Prostate Adenocarcinoma, Erectile Dysfunction, CTCAE Trial in Houston (Atorvastatin, Pentoxifylline,
Completed
- Male Erectile Disorder
- +3 more
- Atorvastatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 21, 2022
Prostate Adenocarcinoma, PSA Level Greater Than Ten, Stage IIB Prostate Cancer AJCC v8 Trial in Houston (Hyperpolarized Carbon C
Active, not recruiting
- Prostate Adenocarcinoma
- +9 more
- Hyperpolarized Carbon C 13 Pyruvate
- Magnetic Resonance Spectroscopic Imaging
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2022
Quantitative HP MRI for Clinical Prostate Cancer Exam
Active, not recruiting
- Prostate Adenocarcinoma
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Prostate Adenocarcinoma Trial in Houston
Completed
- Castration-Resistant Prostate Carcinoma
- +5 more
- Durvalumab
- Tremelimumab
-
Houston, TexasM D Anderson Cancer Center
Nov 9, 2022
Prostate Adenocarcinoma, Prostate Cancer Trial (Transvesical Single Port Robotic Partial Prostatectomy, High-intensity focused
Not yet recruiting
- Prostate Adenocarcinoma
- Prostate Cancer
- Transvesical Single Port Robotic Partial Prostatectomy
- High-intensity focused ultrasound (HIFU)
- (no location specified)
Nov 3, 2022
Prostate Adenocarcinoma Trial in Valence, Clermont-Ferrand, Lyon (Integrated boost)
Recruiting
- Prostate Adenocarcinoma
- Integrated boost
-
Valence, DrĂ´me, France
- +3 more
Oct 26, 2022
Prostate Cancer, Cancer of Prostate, Prostate Adenocarcinoma Trial (Stereotactic Ablative Body Radiation)
Not yet recruiting
- Prostate Cancer
- +2 more
- Stereotactic Ablative Body Radiation
- (no location specified)
Oct 26, 2022
Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))
Active, not recruiting
- Prostate Cancer
- +5 more
- 131I-PSMA-1095 Radioligand Therapy (RLT)
-
Montreal, Quebec, CanadaStephan Probst
Oct 24, 2022